Over a decade into selling Korlym to treat endogenous hypercortisolism, also known as Cushing syndrome, Corcept Therapeutics ...

Bone material strength index values were found to be low in patients with Cushing syndrome even after long-term remission, indicating persistent impairment of tissue-level bone properties.

Salivary cortisol measurements are particularly useful to investigate cyclical Cushing's syndrome. At least partial autonomy of cortisol production (either direct from the adrenal cortex or ...

The phase II DAZALS study evaluating Corcept's dazucorilant in patients with amyotrophic lateral sclerosis fails to meet the primary goal.

Victoria Lucio is a stay-at-home mom of two from Amarillo who has been silently battling with Cushing’s Disease for around ...

Elevated 24-h urine free cortisol (UFC) and suppressed plasma adrenocorticotrophic hormone (ACTH) suggested ACTH-independent Cushing’s syndrome. Ultrasound showed left adrenal mass. She delivered ...

Dechra is running a series of six 30-45 minute webinars about Cushing's in dogs, starting on Tuesday 10th December. The webinars will be presented by ...

Corcept Therapeutics’ selective cortisol modulator failed to slow the progress of amyotrophic lateral sclerosis (ALS) in a ...

Non-hormonal medications can help with depression and anxiety and relieve vaginal dryness. Cushing's disease, a subset of Cushing's syndrome, is an endocrine disorder in which there is too much of the ...

Paltusotine was granted Orphan Drug Designation for the treatment of acromegaly by the FDA in July 2020. This designation is ...

A recent study published in eLife has uncovered a crucial mechanism in cellular material management: endosome maturation. The ...

Ourself, a leader in the next generation of skincare, today announced that clinical data evaluating Ourself's patented delivery technology, Tiered-Release Vesiclestm (TRVs), was published ...